Vita Life Sciences Limited's market cap is currently AU$98.48M. The company's EPS TTM is AU$0.168; its P/E ratio is 10.49; and it has a dividend yield of 5.37%. Vita Life Sciences Limited is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	AU$ 74.16M	AU$ 66.89M	AU$ 57.10M	AU$ 46.48M	AU$ 42.45M
Gross Profit	AU$ 42.60M	AU$ 39.74M	AU$ 34.81M	AU$ 29.27M	AU$ 27.90M
Operating Income	AU$ 12.21M	AU$ 10.77M	AU$ 11.31M	AU$ 8.32M	AU$ 4.57M
EBITDA	AU$ 13.10M	AU$ 11.37M	AU$ 11.71M	AU$ 8.88M	AU$ 5.15M
Net Income	AU$ 9.08M	AU$ 7.08M	AU$ 8.29M	AU$ 6.09M	AU$ 3.14M
Balance Sheet
Cash & Short-Term Investments	AU$ 24.63M	AU$ 15.69M	AU$ 15.89M	AU$ 14.48M	AU$ 10.48M
Total Assets	AU$ 59.81M	AU$ 51.80M	AU$ 45.27M	AU$ 39.10M	AU$ 36.51M
Total Debt	AU$ 387.00K	AU$ 601.00K	AU$ 373.00K	AU$ 2.07M	AU$ 2.35M
Net Debt	AU$ -24.24M	AU$ -15.09M	AU$ -15.52M	AU$ -12.40M	AU$ -8.13M
Total Liabilities	AU$ 16.48M	AU$ 15.30M	AU$ 14.85M	AU$ 14.66M	AU$ 13.98M
Stockholders' Equity	AU$ 43.40M	AU$ 36.57M	AU$ 30.75M	AU$ 24.72M	AU$ 22.60M
Cash Flow
Free Cash Flow	AU$ 12.32M	AU$ 7.54M	AU$ 5.73M	AU$ 7.46M	AU$ 1.45M
Operating Cash Flow	AU$ 12.98M	AU$ 7.68M	AU$ 5.89M	AU$ 7.54M	AU$ 2.03M
Investing Cash Flow	AU$ -660.00K	AU$ -139.00K	AU$ -155.00K	AU$ -89.00K	AU$ -579.00K
Financing Cash Flow	AU$ -2.88M	AU$ -3.10M	AU$ -4.39M	AU$ -3.03M	AU$ -2.74M

Currency in AUD

Vita Life Sciences Limited Earnings and Revenue History

Income Statement >

Vita Life Sciences Limited Debt to Assets

Balance Sheet >

Vita Life Sciences Limited Cash Flow

Cash Flow >

Vita Life Sciences Limited Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing